Shuttle Pharmaceuticals (SHPH)

Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.

Dnešní Shuttle Pharmaceuticals Holdings, Inc. Common Stock (SHPH) cena akcií je 0,92 $, což odpovídá pohybu o -4,02 % od otevřel. Tržní kapitalizace společnosti činí 3,00 mil. $, přičemž denní objem obchodů dosahuje 12,00 $ akcií. Předchozí zavírací cena byla 0,96 $.

Jste připraveni začít? Postupujte podle níže uvedených kroků, nebo si přečtěte naši příručku o jak koupit Shuttle Pharmaceuticals akcie na Kraken s počáteční investicí od 10 USD.